U.S., Liberia kick off trial of Ebola drug ZMapp

A health worker disinfects a road in the Paynesville neighborhood of MonroviaBy Reuters Staff CHICAGO (Reuters) – U.S. and Liberian researchers have started a clinical trial to test the safety and effectiveness of Mapp Biopharmaceutical Inc's Ebola drug ZMapp, an experimental treatment that has already been tried in a handful of Ebola patients, including two U.S. missionaries. The trial, a joint effort by the Liberian government and the National Institute of Allergy and Infectious Diseases (NIAID), will be conducted in Liberia and the United States among adults and children infected with Ebola, NIAID said on Friday.

Go to Source

Doctors should take lead in push to curb climate change: experts

A man walks over a bridge as smoke rises from chimneys of a thermal power plant in ShanghaiBy Kyle Plantz LONDON (Thomson Reuters Foundation) – Doctors should take the lead in supporting political efforts to cut the pace of climate change and encouraging more people to see the problem as a crucial issue for public health, experts say. With the 68th World Health Assembly coming up in May in Geneva, countries are poised to adopt the world's first resolution on air pollution and health, in an effort to reduce premature deaths linked to air pollution. Studies have found that air pollution can worsen a variety of health problems, from heart disease to strokes, said Carlos Dora, coordinator of public health and the environment at the World Health Organization (WHO).

Go to Source

1 2 3 4 53